{"id":"who.who-hepatitis-hcv-treatment-cum-perinfected-crd-per100.bmu.annual","dataset_id":"who-hepatitis-hcv-treatment-cum-perinfected-crd-per100","indicator":"who-hepatitis-hcv-treatment-cum-perinfected-crd-per100","geography":"BMU","frequency":"annual","unit":"percent","start_period":"2015","end_period":"2024","org":"World Health Organization","original_indicator":"HEPATITIS_HCV_TREATMENT_CUM_PERINFECTED_CRD_PER100","url":"https://ghoapi.azureedge.net/api","retrieved_at":"2026-11-08T10:28:13+00:00","version":"1","geography_name":"Bermuda","region":"North America","observations":[{"period":"2015","value":7.47,"flags":""},{"period":"2024","value":39.23,"flags":""}],"indicator_name":"Chronic hepatitis C (HCV) cumulative treatment rate as percentage of total infected, including cured","topic":"Health","source":"who","provenance":{"organization":"World Health Organization","original_indicator":"HEPATITIS_HCV_TREATMENT_CUM_PERINFECTED_CRD_PER100","url":"https://ghoapi.azureedge.net/api","retrieved_at":"2026-11-08T10:28:13+00:00","version":"1","license":"see source"}}